Proton pump inhibitor use represents an independent risk factor for myocardial infarction

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier, Loren Laine, Alise Reicin et al. · New England Journal of Medicine · 2000 · 4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

Ching‐Lan Cheng, Yea‐Huei Kao Yang, Swu‐Jane Lin et al. · Pharmacoepidemiology and Drug Safety · 2010 · 1.3K citations

Medicine, Internal Medicine, Clinical Epidemiology +8

Clopidogrel with or without Omeprazole in Coronary Artery Disease

Deepak L. Bhatt, Byron Cryer, Charles F. Contant et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture

Yu‐Xiao Yang, James D. Lewis, Solomon Epstein et al. · JAMA · 2006 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +16